{"id":"https://openalex.org/W2017887014","doi":"https://doi.org/10.1021/jm040843r","title":"Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1Cannabinoid Receptor Antagonists","display_name":"Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1Cannabinoid Receptor Antagonists","alternate_titles":[],"publication_year":2004,"publication_date":"2004-09-29","ids":{"openalex":"https://openalex.org/W2017887014","doi":"https://doi.org/10.1021/jm040843r","mag":"2017887014","pmid":"https://pubmed.ncbi.nlm.nih.gov/15771428"},"language":"en","primary_location":{"id":"doi:10.1021/jm040843r","doi":"https://doi.org/10.1021/jm040843r","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm040843r","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017887014"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063947698","display_name":"Jos H.M. Lange","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Jos H. M. Lange","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043370236","display_name":"Herman Heinrich van Stuivenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Herman H. van Stuivenberg","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033228073","display_name":"Hein K. A. C. Coolen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hein K. A. C. Coolen","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014547381","display_name":"Tiny J. P. Adolfs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tiny J. P. Adolfs","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022304296","display_name":"Andrew C. McCreary","orcid":"https://orcid.org/0000-0003-3614-9117","observed_orcids":["https://orcid.org/0000-0003-3614-9117"]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Andrew C. McCreary","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006690283","display_name":"Hiskias G. Keizer","orcid":"https://orcid.org/0000-0002-9988-6387","observed_orcids":["https://orcid.org/0000-0002-9988-6387"]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Hiskias G. Keizer","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058119332","display_name":"Henri Cornelis Wals","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Henri C. Wals","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055307150","display_name":"Willem Veerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Willem Veerman","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074734896","display_name":"Alice J. M. Borst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Alice J. M. Borst","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089429388","display_name":"Wouter de Looff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wouter de Looff","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081579588","display_name":"Peter C. Verveer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter C. Verveer","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110019512","display_name":"Chris Gerrit Kruse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163392","display_name":"Solvay (Netherlands)","ror":"https://ror.org/05hxvc906","country_code":"NL","type":"company","lineage":["https://openalex.org/I17170469","https://openalex.org/I4210163392"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Chris G. Kruse","raw_affiliation_strings":["Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Research Laboratories, C. J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands","institution_ids":["https://openalex.org/I4210163392"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5063947698"],"corresponding_institution_ids":["https://openalex.org/I4210163392"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":4.8963,"has_fulltext":false,"cited_by_count":191,"citation_normalized_percentile":{"value":0.95191461,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"48","issue":"6","first_page":"1823","last_page":"1838"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rimonabant","display_name":"rimonabant","score":0.9440000057220459},{"id":"https://openalex.org/keywords/bioisosteres","display_name":"bioisosteres","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cb1-receptor-antagonist","display_name":"CB1 receptor antagonist","score":0.7580000162124634},{"id":"https://openalex.org/keywords/thiazole","display_name":"thiazole","score":0.9490000009536743},{"id":"https://openalex.org/keywords/triazoles","display_name":"triazoles","score":0.9990000128746033},{"id":"https://openalex.org/keywords/imidazole","display_name":"imidazole","score":1.0},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8450000286102295},{"id":"https://openalex.org/keywords/molecular-modeling","display_name":"molecular modeling","score":0.5019999742507935},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C2776433454","wikidata":"https://www.wikidata.org/wiki/Q412529","display_name":"Rimonabant","level":5,"score":0.9656403064727783},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8665416836738586},{"id":"https://openalex.org/C2777682936","wikidata":"https://www.wikidata.org/wiki/Q408908","display_name":"Pyrazole","level":2,"score":0.7677522897720337},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.7557646036148071},{"id":"https://openalex.org/C2780871563","wikidata":"https://www.wikidata.org/wiki/Q422936","display_name":"Cannabinoid","level":3,"score":0.71921706199646},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.653796374797821},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6408860683441162},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5596978664398193},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.5311319231987},{"id":"https://openalex.org/C2778464347","wikidata":"https://www.wikidata.org/wiki/Q413426","display_name":"Thiazole","level":2,"score":0.5002005100250244},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.48868802189826965},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.44266849756240845},{"id":"https://openalex.org/C2780874372","wikidata":"https://www.wikidata.org/wiki/Q328692","display_name":"Imidazole","level":2,"score":0.41076022386550903},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4105130136013031},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37643730640411377},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3670560121536255},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.31512272357940674},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16019517183303833},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077285","descriptor_name":"Rimonabant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003412","descriptor_name":"Cricetulus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007022","descriptor_name":"Hypotension","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007035","descriptor_name":"Hypothermia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D016466","descriptor_name":"CHO Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D043885","descriptor_name":"Receptor, Cannabinoid, CB2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm040843r","doi":"https://doi.org/10.1021/jm040843r","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm040843r","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:15771428","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15771428","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.46810001134872437,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W84164735","https://openalex.org/W659638591","https://openalex.org/W1685180105","https://openalex.org/W1931308193","https://openalex.org/W1965534002","https://openalex.org/W1977929532","https://openalex.org/W1983357954","https://openalex.org/W1990252792","https://openalex.org/W1991461690","https://openalex.org/W1994595807","https://openalex.org/W2004152335","https://openalex.org/W2004485518","https://openalex.org/W2013382945","https://openalex.org/W2018488725","https://openalex.org/W2026198371","https://openalex.org/W2031342779","https://openalex.org/W2039297169","https://openalex.org/W2044829512","https://openalex.org/W2051033111","https://openalex.org/W2053070543","https://openalex.org/W2056188558","https://openalex.org/W2059178792","https://openalex.org/W2066012098","https://openalex.org/W2074697485","https://openalex.org/W2076227819","https://openalex.org/W2081183340","https://openalex.org/W2088747854","https://openalex.org/W2098569377","https://openalex.org/W2099348408","https://openalex.org/W2102118525","https://openalex.org/W2130587723","https://openalex.org/W2135475275","https://openalex.org/W2157518435","https://openalex.org/W2160701769","https://openalex.org/W2182593958","https://openalex.org/W2748647222","https://openalex.org/W2951079971","https://openalex.org/W2998257365","https://openalex.org/W4205135512","https://openalex.org/W4238140818"],"related_works":["https://openalex.org/W2026102697","https://openalex.org/W2084475891","https://openalex.org/W1975521618","https://openalex.org/W2144114917","https://openalex.org/W2133254875","https://openalex.org/W2034601932","https://openalex.org/W2024637104","https://openalex.org/W2411014101","https://openalex.org/W2031888061","https://openalex.org/W2129611804"],"abstract_inverted_index":{"Series":[0],"of":[1,29,71],"thiazoles,":[2,44],"triazoles,":[3,45],"and":[4,34,39,46,54,99,119,137],"imidazoles":[5,47],"were":[6],"designed":[7],"as":[8],"bioisosteres,":[9],"based":[10],"on":[11],"the":[12,19,72,80,115,131,135],"1,5-diarylpyrazole":[13],"motif":[14],"that":[15],"is":[16],"present":[17],"in":[18,36,49,55,79,86,92,134],"potent":[20,84],"CB(1)":[21,59],"receptor":[22,41,62],"antagonist":[23],"rimonabant":[24],"(SR141716A,":[25],"1).":[26],"A":[27,121],"number":[28],"target":[30],"compounds":[31],"was":[32],"synthesized":[33],"evaluated":[35],"cannabinoid":[37,69],"(hCB(1)":[38],"hCB(2))":[40],"assays.":[42],"The":[43],"elicited":[48],"vitro(":[50],")()CB(1)":[51],"antagonistic":[52],"activities":[53,88],"general":[56],"exhibited":[57],"considerable":[58],"vs":[60],"CB(2)":[61],"subtype":[63],"selectivities,":[64],"thereby":[65],"demonstrating":[66],"to":[67],"be":[68],"bioisosteres":[70],"original":[73],"diarylpyrazole":[74],"class.":[75],"Some":[76],"key":[77,116],"representatives":[78],"imidazole":[81,136],"series":[82],"showed":[83,108],"pharmacological":[85],"vivo":[87],"after":[89],"oral":[90],"administration":[91],"both":[93],"a":[94,100,109,127],"CB":[95,101],"agonist-induced":[96,102],"hypotension":[97],"model":[98],"hypothermia":[103],"model.":[104],"Molecular":[105],"modeling":[106],"studies":[107],"close":[110,128],"three-dimensional":[111],"structural":[112],"overlap":[113],"between":[114,130],"compound":[117],"62":[118],"rimonabant.":[120],"structure-activity":[122],"relationship":[123],"(SAR)":[124],"study":[125],"revealed":[126],"correlation":[129],"biological":[132],"results":[133],"pyrazole":[138],"series.":[139]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017887014","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
